Prevalence of manifested drug-drug interactions in intensive care patients with cardiovascular diseases
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: OLIVEIRA-FILHO, Alfredo (Federal University of Alagoas, Department of Pharmacy and Nursery - ESENFAR, Maceió, Brazil)
- Co-author(s): Rocha, L.R.M. (Federal University of Alagoas, Maceió, Brazil)
Neves, S.J.F. (Federal University of Alagoas, Maceió, Brazil)
Costa, F.A. (Federal University of Alagoas, Maceió, Brazil)
Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. This study aimed to identify the prevalence of clinically manifested drug-drug interactions (DDIs) in the drug regimens The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.